search
Back to results

A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT

Primary Purpose

Gestational Diabetes Mellitus

Status
Completed
Phase
Not Applicable
Locations
Norway
Study Type
Interventional
Intervention
Pregnant+ app for smartphone
Sponsored by
Oslo Metropolitan University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Gestational Diabetes Mellitus focused on measuring Gestational diabetes, app, RCT, diet, physical activity

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • First visit with gestational diabetes in this pregnancy
  • Has her own smartphone
  • Pregnancy up to 32 weeks and 6 days of gestation
  • Fluent in Norwegian, Urdu or Somali
  • Aged 18 years old and older

Exclusion Criteria:

  • Pregnant with more than one fetus
  • Lactose or gluten intolerance
  • Known type 1 diabetes (insulin dependent)
  • Known type 2 diabetes

Sites / Locations

  • Oslo university hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Pregnant+ app for smartphone (Gravid+)

No admission to Pregnant+ app (Gravid+)

Arm Description

The intervention consists of the Pregnant+app downloaded on women's smartphone. The app contains culturally adapted information about physical activity, diet and management of GDM. The Gravid+app will be available in Norwegain, Urdu and Somali. Women will have the opportunity to automatically transfer their blood glucose levels to their smartphones via Bluetooth.

The control group will receive standard care at the outpatient departments. Participants to not receive the Pregnancy

Outcomes

Primary Outcome Measures

Oral glucose tolerance test (OGTT), fasting and 2 hours blood glucose level after intake up til 75gr glucose (1.75gr/kg body weight)
Part of routine care for women who had GDM, is an OGTT about three months postpartum, taken at their laboratory and reported to the investigators.Number of participants with level below 7.5 mmol

Secondary Outcome Measures

complications of pregnancy
Raised BP, vaginal bleeding, amniotic fluid leakage, preeclampsia, nausea and vomitting, Braxton Hicks Contractions, UTI, Candida vaginal infection, pelvic girdle pain
Dietary intake measured by "Fit for fødsel Food questionnaire"
Fit for fødsel Food questionnaire, 41 questions. Number of participants following ten items of advice on low glucose, high fiber diet.
Knowledge of gestational diabetes
7 questions assessing knowledge of gestational diabetes and understanding of glucose measurements and control of those. Number of participants with high understanding of GDM at 36 weeks, and number of participants with increasing knowledge.
Physical activity
PPAQ:Pregnancy Physical Activity Questionnaire (37 questions). Comparison of participants in both arms of the study for Level of physical activity. Number of participants with low, moderate or high level of activity.
Depression
Edinburgh Depression Scale- short version, 5 questions. Number of participants with depression. Cut-off at either total score of 7 or 8.
Motivation for physical activity
4 questions assessing women's motivation to be physically active, number of women with high score and increasing score.
Motivation for eating healthy
3 questions assessing women's motivation to eat healthy, number of women with high score and increasing score.
Mode of delivery and complications at birth for the mother
From the Medical records, number of women for each group: induction, mode of delivery, shoulderdystocia, postpartum haemorrhage, Sphincter rupture, episiotomi, manual removal of placenta, Hb below 11 gr/dl, infection, removal of retained products.
Complications for the newborn
Number of newborns who were transferred to intensive care unit, who were diagnosed with hypoglycaemia, information from the Medical records.
Condition of the newborn
Number of newborns with Apgar score below 7 at 5 minutes, birth weight above different cut-offs (3.5 kg and 4kg), full breastfeeding and other nutrition from pasient notes and 3 months postpartum questionnaire.
Starting medication for controlling blood glucose levels for the pregnant woman
Number of patients who start to use insulin or Metformin during pregnancy, information from the patient notes
Blood glucose control during pregnancy
Number of patients with, fasting glucose over 5.5 gr/dl, HbA1c above 7.0% at 30,32,34,36,38 and 40 weeks
HbA1c
Measured at home by visiting researcher, finger prick blood.

Full Information

First Posted
August 31, 2015
Last Updated
April 4, 2018
Sponsor
Oslo Metropolitan University
Collaborators
Universitetssenteret på Kjeller, Oslo University Hospital, Vestre Viken Hospital Trust, University Hospital, Akershus, The Norwegian Centre for Minority Health Research
search

1. Study Identification

Unique Protocol Identification Number
NCT02588729
Brief Title
A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT
Official Title
A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With Gestational Diabetes Mellitus - RCT
Study Type
Interventional

2. Study Status

Record Verification Date
April 2018
Overall Recruitment Status
Completed
Study Start Date
October 2015 (Actual)
Primary Completion Date
December 2017 (Actual)
Study Completion Date
December 2017 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Oslo Metropolitan University
Collaborators
Universitetssenteret på Kjeller, Oslo University Hospital, Vestre Viken Hospital Trust, University Hospital, Akershus, The Norwegian Centre for Minority Health Research

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study, the investigators will test a new way to communicate advice on diet and lifestyle to women with gestational diabetes mellitus by app downloaded on women's smartphone. The app wishes to motivate women to have a healthy diet, and be physically active. It allows automatic transfer of blood glucose measures from the glucose meter to the smartphone. The women will answer questionnaires during pregnancy and be followed up three months postpartum.
Detailed Description
Gestational diabetes mellitus (GDM), diabetes occuring for the first time during pregnancy, is an increasing problem worldwide. It may affect both the woman's and their offspring's health. Women with GDM have an increased risk of developing type 2 diabetes later in life. Pregnancy, offers a window of opportunity to instigate lasting changes beneficial for them and their families. Considering new technology available and used by women generally, new methods to communicate lifestyle and dietary advice are required. The present study, a multi-center, randomised controlled trial includes five outpatients clinics in the greater Oslo Region and will include 230 pregnant women with gestational diabets mellitus. Data will be collected by three questionnaires during the study period, one at entry, before 33+0 weeks of gestation, one at 36 weeks and the last questionnaire at around three months postpartum. During pregnancy, the questionniares will be answered using an iPad while the last questionnaire will be on a website or through an interview. Additional information will be collected from the women's medical record. The intervention in this study is an app, called the Pregnant+ app (Gravid+) for smartphone. The app aims to reach women who are fluent in either Norwegian, Urdu or Somali. It has been translated from Norwegian and culturally adapted to women speaking Urdu or Somali. Women participating in the study can choose between different food cultures and they can set their personal lifestyle goals. Information about gestational diabetes, psysical activity, diet and food recipes are provided in the app. Half of the women in this study, will be given the app, downloaded on their smartphone.The opportunity to automatically transfer bloodglucose measures to the smartphone, presented in either a list or a graph, gives women an overview and therefore easier controll over their glucose levels. The intervention will take place in the ordinary consultation at the outpatient clinics and no extra consultation are needed. The data will be analysed according to intention to treat methods and with a parcicipatin rate on 75% it will take approximately 20 months to recruite 230 pregnant women. To detect a differences of 10% between the intervention group and the control group, 115 women are required in each group. The Regional Committees for Medical and Health Research Ethics South East, (REK) reviewed the investigators' application and deemed ethical approval not required as the investigators' study does not test new medication or treatment, nor seeks to find new information about GDM but only tests a new way of communicating known and approved lifestyle advice to women with GDM. For each hospital the investigators received approval from the appropriate Board for patient privacy protection (PVO: Personvernombud). The study was approved at each hospital by the responsible medical officer. The investigators' study has been approved by the Norwegian Social Science Data Services. The RCT will be published in an international peer-reviewed scientific journal.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Gestational Diabetes Mellitus
Keywords
Gestational diabetes, app, RCT, diet, physical activity

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
238 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Pregnant+ app for smartphone (Gravid+)
Arm Type
Experimental
Arm Description
The intervention consists of the Pregnant+app downloaded on women's smartphone. The app contains culturally adapted information about physical activity, diet and management of GDM. The Gravid+app will be available in Norwegain, Urdu and Somali. Women will have the opportunity to automatically transfer their blood glucose levels to their smartphones via Bluetooth.
Arm Title
No admission to Pregnant+ app (Gravid+)
Arm Type
No Intervention
Arm Description
The control group will receive standard care at the outpatient departments. Participants to not receive the Pregnancy
Intervention Type
Other
Intervention Name(s)
Pregnant+ app for smartphone
Intervention Description
The Pregnant+app for smartphone with information about a healthy diet, physical activity and management of gestational diabetes mellitus.
Primary Outcome Measure Information:
Title
Oral glucose tolerance test (OGTT), fasting and 2 hours blood glucose level after intake up til 75gr glucose (1.75gr/kg body weight)
Description
Part of routine care for women who had GDM, is an OGTT about three months postpartum, taken at their laboratory and reported to the investigators.Number of participants with level below 7.5 mmol
Time Frame
Approximately three months after delivery.
Secondary Outcome Measure Information:
Title
complications of pregnancy
Description
Raised BP, vaginal bleeding, amniotic fluid leakage, preeclampsia, nausea and vomitting, Braxton Hicks Contractions, UTI, Candida vaginal infection, pelvic girdle pain
Time Frame
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum
Title
Dietary intake measured by "Fit for fødsel Food questionnaire"
Description
Fit for fødsel Food questionnaire, 41 questions. Number of participants following ten items of advice on low glucose, high fiber diet.
Time Frame
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation and up to 4 months postpartum
Title
Knowledge of gestational diabetes
Description
7 questions assessing knowledge of gestational diabetes and understanding of glucose measurements and control of those. Number of participants with high understanding of GDM at 36 weeks, and number of participants with increasing knowledge.
Time Frame
Data will be collected prior to 33 weeks gestation, and at 36 weeks gestation
Title
Physical activity
Description
PPAQ:Pregnancy Physical Activity Questionnaire (37 questions). Comparison of participants in both arms of the study for Level of physical activity. Number of participants with low, moderate or high level of activity.
Time Frame
Data wil be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
Title
Depression
Description
Edinburgh Depression Scale- short version, 5 questions. Number of participants with depression. Cut-off at either total score of 7 or 8.
Time Frame
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
Title
Motivation for physical activity
Description
4 questions assessing women's motivation to be physically active, number of women with high score and increasing score.
Time Frame
Data will be collected prior to 33 weeks gestation, at 36 weeks gestation, up to 4 months postpartum
Title
Motivation for eating healthy
Description
3 questions assessing women's motivation to eat healthy, number of women with high score and increasing score.
Time Frame
Data will be collected prior to 33 weeks gestation, at 36 weeks, up to 4 months postpartum
Title
Mode of delivery and complications at birth for the mother
Description
From the Medical records, number of women for each group: induction, mode of delivery, shoulderdystocia, postpartum haemorrhage, Sphincter rupture, episiotomi, manual removal of placenta, Hb below 11 gr/dl, infection, removal of retained products.
Time Frame
at birth
Title
Complications for the newborn
Description
Number of newborns who were transferred to intensive care unit, who were diagnosed with hypoglycaemia, information from the Medical records.
Time Frame
at birth
Title
Condition of the newborn
Description
Number of newborns with Apgar score below 7 at 5 minutes, birth weight above different cut-offs (3.5 kg and 4kg), full breastfeeding and other nutrition from pasient notes and 3 months postpartum questionnaire.
Time Frame
at birth and approx three months postpartum
Title
Starting medication for controlling blood glucose levels for the pregnant woman
Description
Number of patients who start to use insulin or Metformin during pregnancy, information from the patient notes
Time Frame
during pregnancy
Title
Blood glucose control during pregnancy
Description
Number of patients with, fasting glucose over 5.5 gr/dl, HbA1c above 7.0% at 30,32,34,36,38 and 40 weeks
Time Frame
during pregnancy
Title
HbA1c
Description
Measured at home by visiting researcher, finger prick blood.
Time Frame
Approx three months postpartum

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: First visit with gestational diabetes in this pregnancy Has her own smartphone Pregnancy up to 32 weeks and 6 days of gestation Fluent in Norwegian, Urdu or Somali Aged 18 years old and older Exclusion Criteria: Pregnant with more than one fetus Lactose or gluten intolerance Known type 1 diabetes (insulin dependent) Known type 2 diabetes
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mirjam Lukasse, PhD
Organizational Affiliation
Oslo Metropolitan University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Oslo university hospital
City
Oslo
ZIP/Postal Code
4950
Country
Norway

12. IPD Sharing Statement

Citations:
PubMed Identifier
27417764
Citation
Garnweidner-Holme LM, Borgen I, Garitano I, Noll J, Lukasse M. Designing and Developing a Mobile Smartphone Application for Women with Gestational Diabetes Mellitus Followed-Up at Diabetes Outpatient Clinics in Norway. Healthcare (Basel). 2015 May 21;3(2):310-23. doi: 10.3390/healthcare3020310.
Results Reference
background
PubMed Identifier
34979996
Citation
Garnweidner-Holme L, Henriksen L, Bjerkan K, Lium J, Lukasse M. Factors associated with the level of physical activity in a multi-ethnic pregnant population - a cross-sectional study at the time of diagnosis with gestational diabetes. BMC Pregnancy Childbirth. 2022 Jan 3;22(1):1. doi: 10.1186/s12884-021-04335-x.
Results Reference
derived
PubMed Identifier
33146620
Citation
Garnweidner-Holme L, Henriksen L, Torheim LE, Lukasse M. Effect of the Pregnant+ Smartphone App on the Dietary Behavior of Women With Gestational Diabetes Mellitus: Secondary Analysis of a Randomized Controlled Trial. JMIR Mhealth Uhealth. 2020 Nov 4;8(11):e18614. doi: 10.2196/18614.
Results Reference
derived
PubMed Identifier
31719080
Citation
Borgen I, Smastuen MC, Jacobsen AF, Garnweidner-Holme LM, Fayyad S, Noll J, Lukasse M. Effect of the Pregnant+ smartphone application in women with gestational diabetes mellitus: a randomised controlled trial in Norway. BMJ Open. 2019 Nov 11;9(11):e030884. doi: 10.1136/bmjopen-2019-030884.
Results Reference
derived
PubMed Identifier
28348183
Citation
Borgen I, Garnweidner-Holme LM, Jacobsen AF, Bjerkan K, Fayyad S, Joranger P, Lilleengen AM, Mosdol A, Noll J, Smastuen MC, Terragni L, Torheim LE, Lukasse M. Smartphone application for women with gestational diabetes mellitus: a study protocol for a multicentre randomised controlled trial. BMJ Open. 2017 Mar 27;7(3):e013117. doi: 10.1136/bmjopen-2016-013117.
Results Reference
derived
Links:
URL
http://www.mdpi.com/2227-9032/3/2/310
Description
This article descibe the process of designing and developing the Gravid+app. The effect of the app will be tested in a randomized controlled trial.

Learn more about this trial

A Mobile Smartphone Application to Promote a Healthy Diet and Physical Activity Among Pregnant Women With GDM - RCT

We'll reach out to this number within 24 hrs